CN Stock MarketDetailed Quotes

002020 Zhejiang Jingxin Pharmaceutical

Watchlist
  • 12.86
  • +0.25+1.98%
Market Closed Dec 6 15:00 CST
11.07BMarket Cap15.35P/E (TTM)

Zhejiang Jingxin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-80.37%244.04M
-69.04%459.58M
37.87%2.07B
-5.66%1.46B
-19.44%1.24B
-0.51%1.48B
-9.32%1.5B
-0.78%1.55B
9.55%1.54B
81.05%1.49B
Transactional financial assets
376.59%865.55M
258.41%811.85M
-65.71%110.15M
-58.85%150.96M
-38.56%181.61M
50.38%226.51M
146.88%321.27M
-13.14%366.89M
-37.25%295.58M
-75.55%150.63M
Notes receivable and accounts receivable
56.16%776.13M
59.69%722.3M
12.92%536.41M
20.45%571.46M
0.60%497.02M
-18.31%452.32M
-3.72%475.04M
3.05%474.43M
9.33%494.08M
18.98%553.68M
-Accounts receivable
56.16%776.13M
59.69%722.3M
12.92%536.41M
20.45%571.46M
0.60%497.02M
-18.31%452.32M
-3.72%475.04M
3.05%474.43M
9.33%494.08M
18.98%553.68M
Other receivables (including interest and dividends)
93.75%62.51M
-4.01%38.77M
-12.72%33.24M
-29.02%28.14M
-38.11%32.26M
-23.61%40.39M
-58.59%38.09M
-55.02%39.65M
-18.40%52.13M
-6.74%52.87M
-Other receivable
----
-4.01%38.77M
----
----
----
-23.61%40.39M
----
-55.02%39.65M
----
-6.74%52.87M
Advance payment
3.07%17.56M
17.55%18.05M
-37.19%16.44M
-35.92%13.33M
3.43%17.03M
-4.61%15.35M
18.80%26.17M
16.87%20.81M
-63.93%16.47M
32.31%16.1M
Inventories
11.84%757.73M
-3.30%699.52M
-14.48%649.92M
-15.64%652.69M
-15.35%677.51M
-8.93%723.42M
11.44%759.95M
14.17%773.7M
39.89%800.38M
43.96%794.37M
Receivable financing
125.24%99.82M
-53.71%20.71M
-59.93%37.93M
17.02%41.12M
-15.07%44.32M
11.46%44.73M
89.17%94.67M
-30.07%35.14M
2.05%52.18M
-19.18%40.13M
Non-current assets due within one year
--67.86M
--187.74M
--184.98M
--408.16M
----
----
----
----
----
----
Other current assets
-53.48%18.95M
2.53%32.87M
15.29%24.84M
22.59%27.07M
138.23%40.74M
4.10%32.06M
11.28%21.55M
33.90%22.08M
-80.55%17.1M
-64.67%30.79M
Total current assets
6.46%2.91B
-0.93%2.99B
13.15%3.66B
2.21%3.35B
-16.43%2.73B
-3.56%3.02B
2.98%3.24B
-0.39%3.28B
3.77%3.27B
17.56%3.13B
Non Current assets
Other non-current financial assets
6.84%549.78M
6.86%549.79M
6.84%549.79M
8.98%549.79M
89.46%514.58M
41.57%514.49M
45.67%514.58M
44.62%504.49M
-35.21%271.61M
-13.31%363.42M
Investment real estate
161.01%338.34M
160.97%341.53M
160.61%344.29M
160.33%347.15M
-2.51%129.62M
-2.48%130.87M
-2.46%132.11M
-2.44%133.35M
-3.60%132.96M
-3.57%134.2M
Long-term equity investment
-24.70%60.26M
-24.69%60.27M
-23.13%62.52M
-23.13%62.52M
-75.06%80.03M
-24.46%80.03M
-24.55%81.33M
-24.55%81.33M
149.71%320.94M
-16.94%105.94M
Fixed assets
----
69.84%2.24B
----
----
----
18.83%1.32B
----
18.27%1.29B
----
22.64%1.11B
Constru in process
----
-92.08%40.33M
----
----
----
89.73%509.42M
----
76.59%284.91M
----
3.69%268.5M
Intangible assets
-4.89%387.06M
-4.56%392.35M
-4.40%397.96M
-4.14%401.26M
0.67%406.98M
1.17%411.11M
5.89%416.28M
166.61%418.59M
181.83%404.27M
178.45%406.35M
Goodwill
0.00%348.48M
0.00%348.48M
0.00%348.48M
0.00%348.48M
-3.51%348.48M
-3.51%348.48M
-3.51%348.48M
0.00%348.48M
40.05%361.18M
40.05%361.18M
Long deferred expense
180.14%63.35M
90.16%41.12M
-3.05%19.69M
-20.63%21.2M
-28.95%22.61M
-46.39%21.62M
-58.34%20.31M
-52.26%26.71M
-39.38%31.83M
-33.02%40.34M
Deferred tax assets
19.39%82.22M
40.98%87.6M
38.86%85.89M
7.83%80.98M
9.60%68.86M
-1.11%62.14M
-1.54%61.85M
9.42%75.11M
42.90%62.83M
42.90%62.83M
Usufruct assets
-21.22%35.97M
-26.88%35.07M
-23.48%39.43M
-23.64%42.79M
42.37%45.65M
30.66%47.97M
31.63%51.53M
27.71%56.03M
65.96%32.07M
67.30%36.71M
Other non current assets
31.82%1.61B
21.71%1.33B
-51.49%483.38M
-39.47%521.23M
84.06%1.22B
60.03%1.1B
57.96%996.51M
17.51%861.19M
15.89%663.23M
47.32%684.41M
Total non current assets
16.09%5.67B
20.48%5.47B
8.11%4.67B
13.51%4.63B
30.57%4.89B
27.04%4.54B
25.86%4.32B
25.46%4.08B
25.15%3.74B
25.64%3.57B
Total assets
12.64%8.58B
11.93%8.46B
10.27%8.33B
8.48%7.99B
8.65%7.62B
12.76%7.56B
14.91%7.55B
12.46%7.36B
14.18%7.01B
21.73%6.71B
Liabilities
Current liabilities
Short term loan
-2.04%352M
28.58%462M
44.80%332M
16.98%279.09M
50.30%359.32M
56.86%359.32M
54.58%229.29M
60.85%238.58M
139.07%239.07M
129.07%229.07M
Notes payable and accounts payable
40.98%1.1B
20.64%1.07B
30.36%1.04B
30.88%941.16M
12.54%779.95M
40.54%883.48M
70.34%799.28M
59.88%719.12M
53.62%693.07M
33.16%628.66M
-Notes payable
19.28%467.76M
-15.25%381.97M
-15.93%354.49M
-4.02%330.31M
2.11%392.16M
61.19%450.72M
115.71%421.66M
60.84%344.15M
68.06%384.06M
6.27%279.62M
-Accounts payable
62.92%631.79M
58.02%683.88M
82.04%687.43M
62.90%610.85M
25.49%387.79M
23.99%432.77M
37.94%377.62M
59.01%374.97M
38.80%309.02M
67.01%349.04M
Contract liabilities
-24.45%35.78M
-34.82%29.21M
-53.87%44.34M
-34.15%53.35M
-0.40%47.36M
2.15%44.82M
62.64%96.12M
70.15%81.01M
-22.11%47.55M
-7.28%43.88M
Advance receipts
--0
----
--0
--0
--0
----
----
----
--0
--0
Salaries payable
27.82%147.02M
30.59%134.68M
18.56%147.58M
14.53%164.77M
3.70%115.01M
-0.97%103.13M
-1.86%124.48M
1.46%143.86M
-10.06%110.91M
-4.58%104.14M
Taxs payable
91.15%71.31M
119.55%85.14M
7.92%78.81M
-16.61%87.92M
-54.22%37.31M
-44.67%38.78M
-16.55%73.03M
6.70%105.43M
172.14%81.49M
219.31%70.1M
Other payable (including interest and dividends)
28.19%642.24M
22.49%620.34M
12.05%586.06M
5.76%532.35M
2.01%500.99M
-8.40%506.44M
-3.13%523.05M
-2.45%503.37M
-7.09%491.14M
-1.01%552.91M
-Other payable
----
22.49%620.34M
----
----
----
-8.40%506.44M
----
-2.45%503.37M
----
-1.01%552.91M
Non current liabilities due within one year
11.97%11.85M
0.07%10.96M
6.45%11.22M
-19.51%11.86M
12.03%10.58M
-4.31%10.95M
-14.56%10.54M
-1.31%14.73M
--9.45M
--11.44M
Other current liabilities
-49.63%2.99M
-48.33%2.89M
-27.29%4.7M
-54.03%4.26M
16.98%5.93M
41.83%5.59M
54.64%6.47M
85.44%9.28M
-20.61%5.07M
-11.98%3.94M
Total current liabilities
27.27%2.36B
23.49%2.41B
20.64%2.25B
14.29%2.07B
10.65%1.86B
18.76%1.95B
28.65%1.86B
27.64%1.82B
29.01%1.68B
25.17%1.64B
Current liabilities
Long term loan
----
----
--0
----
--0
----
----
----
----
-95.49%21.45K
Estimate liabilities
-32.49%1.31M
64.98%3.2M
46.79%2.85M
64.98%3.2M
168.39%1.94M
168.39%1.94M
161.14%1.94M
161.14%1.94M
-8.17%723.3K
-8.17%723.3K
Deferred tax liabilities
28.93%75.46M
32.95%76.19M
26.96%70.69M
14.60%68.4M
3.23%58.53M
1.07%57.3M
-1.82%55.68M
-8.79%59.68M
21.80%56.7M
21.80%56.7M
Long term deferred income
-6.69%259.57M
-4.59%267.07M
-1.13%264.82M
-0.66%268.81M
6.57%278.19M
71.98%279.9M
110.06%267.84M
110.20%270.6M
108.40%261.05M
26.24%162.75M
Lease liabilities
-37.90%24.06M
-48.36%20.05M
-27.64%30.78M
-27.34%31.23M
50.31%38.74M
41.03%38.82M
48.84%42.53M
40.38%42.98M
33.89%25.77M
26.38%27.52M
Total non current liabilities
-4.51%360.4M
-3.03%366.5M
0.31%369.13M
-0.95%371.64M
9.63%377.4M
52.58%377.96M
72.31%367.99M
66.33%375.2M
79.07%344.24M
24.78%247.71M
Total liabilities
21.90%2.72B
19.18%2.78B
17.29%2.62B
11.68%2.45B
10.48%2.23B
23.19%2.33B
34.27%2.23B
32.94%2.19B
35.46%2.02B
25.12%1.89B
Shareholders equity
Paid-in capital
0.00%861.03M
0.00%861.03M
0.00%861.03M
0.00%861.03M
0.00%861.03M
-4.89%861.03M
-4.89%861.03M
-4.89%861.03M
-4.89%861.03M
8.07%905.32M
Capital reserve funds
0.18%1.72B
0.18%1.72B
0.18%1.72B
0.18%1.72B
0.72%1.72B
-18.13%1.72B
-18.13%1.72B
-23.07%1.72B
-22.11%1.71B
19.03%2.1B
Surplus reserve funds
15.19%374.11M
15.19%374.11M
15.19%374.11M
15.19%374.11M
16.90%324.77M
16.90%324.77M
16.90%324.77M
16.90%324.77M
31.17%277.83M
31.17%277.83M
Retained profit
16.93%2.86B
17.38%2.68B
13.92%2.71B
13.96%2.54B
15.68%2.44B
18.22%2.29B
16.91%2.38B
19.07%2.23B
20.52%2.11B
21.34%1.93B
Less:Treasury stock
----
----
--0
----
--0
--0
----
----
--0
0.00%437.62M
Other composite income
-38.97%1.24M
-26.70%1.42M
-12.98%1.31M
-24.33%1.04M
178.93%2.04M
353.72%1.94M
430.53%1.51M
1,749.25%1.37M
483.11%731.34K
272.25%427K
Specific reserves
29.15%12.82M
29.04%12.82M
29.11%12.82M
29.04%12.82M
24.55%9.93M
24.66%9.94M
24.59%9.93M
24.66%9.94M
26.93%7.97M
26.93%7.97M
Shareholders equity without minority interests
8.73%5.83B
8.69%5.66B
7.29%5.68B
7.12%5.51B
7.93%5.36B
8.67%5.2B
8.31%5.3B
5.85%5.15B
7.27%4.97B
20.41%4.79B
Minority interests
21.49%30.57M
10.57%28.78M
14.32%30.2M
7.48%27.78M
4.77%25.16M
6.60%26.03M
21.11%26.41M
-31.47%25.85M
26.75%24.02M
30.09%24.42M
Total shareholder equity
8.79%5.86B
8.70%5.69B
7.33%5.71B
7.12%5.54B
7.91%5.39B
8.66%5.23B
8.37%5.32B
5.57%5.17B
7.34%4.99B
20.45%4.81B
Total liabilityies and equity
12.64%8.58B
11.93%8.46B
10.27%8.33B
8.48%7.99B
8.65%7.62B
12.76%7.56B
14.91%7.55B
12.46%7.36B
14.18%7.01B
21.73%6.71B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -80.37%244.04M-69.04%459.58M37.87%2.07B-5.66%1.46B-19.44%1.24B-0.51%1.48B-9.32%1.5B-0.78%1.55B9.55%1.54B81.05%1.49B
Transactional financial assets 376.59%865.55M258.41%811.85M-65.71%110.15M-58.85%150.96M-38.56%181.61M50.38%226.51M146.88%321.27M-13.14%366.89M-37.25%295.58M-75.55%150.63M
Notes receivable and accounts receivable 56.16%776.13M59.69%722.3M12.92%536.41M20.45%571.46M0.60%497.02M-18.31%452.32M-3.72%475.04M3.05%474.43M9.33%494.08M18.98%553.68M
-Accounts receivable 56.16%776.13M59.69%722.3M12.92%536.41M20.45%571.46M0.60%497.02M-18.31%452.32M-3.72%475.04M3.05%474.43M9.33%494.08M18.98%553.68M
Other receivables (including interest and dividends) 93.75%62.51M-4.01%38.77M-12.72%33.24M-29.02%28.14M-38.11%32.26M-23.61%40.39M-58.59%38.09M-55.02%39.65M-18.40%52.13M-6.74%52.87M
-Other receivable -----4.01%38.77M-------------23.61%40.39M-----55.02%39.65M-----6.74%52.87M
Advance payment 3.07%17.56M17.55%18.05M-37.19%16.44M-35.92%13.33M3.43%17.03M-4.61%15.35M18.80%26.17M16.87%20.81M-63.93%16.47M32.31%16.1M
Inventories 11.84%757.73M-3.30%699.52M-14.48%649.92M-15.64%652.69M-15.35%677.51M-8.93%723.42M11.44%759.95M14.17%773.7M39.89%800.38M43.96%794.37M
Receivable financing 125.24%99.82M-53.71%20.71M-59.93%37.93M17.02%41.12M-15.07%44.32M11.46%44.73M89.17%94.67M-30.07%35.14M2.05%52.18M-19.18%40.13M
Non-current assets due within one year --67.86M--187.74M--184.98M--408.16M------------------------
Other current assets -53.48%18.95M2.53%32.87M15.29%24.84M22.59%27.07M138.23%40.74M4.10%32.06M11.28%21.55M33.90%22.08M-80.55%17.1M-64.67%30.79M
Total current assets 6.46%2.91B-0.93%2.99B13.15%3.66B2.21%3.35B-16.43%2.73B-3.56%3.02B2.98%3.24B-0.39%3.28B3.77%3.27B17.56%3.13B
Non Current assets
Other non-current financial assets 6.84%549.78M6.86%549.79M6.84%549.79M8.98%549.79M89.46%514.58M41.57%514.49M45.67%514.58M44.62%504.49M-35.21%271.61M-13.31%363.42M
Investment real estate 161.01%338.34M160.97%341.53M160.61%344.29M160.33%347.15M-2.51%129.62M-2.48%130.87M-2.46%132.11M-2.44%133.35M-3.60%132.96M-3.57%134.2M
Long-term equity investment -24.70%60.26M-24.69%60.27M-23.13%62.52M-23.13%62.52M-75.06%80.03M-24.46%80.03M-24.55%81.33M-24.55%81.33M149.71%320.94M-16.94%105.94M
Fixed assets ----69.84%2.24B------------18.83%1.32B----18.27%1.29B----22.64%1.11B
Constru in process -----92.08%40.33M------------89.73%509.42M----76.59%284.91M----3.69%268.5M
Intangible assets -4.89%387.06M-4.56%392.35M-4.40%397.96M-4.14%401.26M0.67%406.98M1.17%411.11M5.89%416.28M166.61%418.59M181.83%404.27M178.45%406.35M
Goodwill 0.00%348.48M0.00%348.48M0.00%348.48M0.00%348.48M-3.51%348.48M-3.51%348.48M-3.51%348.48M0.00%348.48M40.05%361.18M40.05%361.18M
Long deferred expense 180.14%63.35M90.16%41.12M-3.05%19.69M-20.63%21.2M-28.95%22.61M-46.39%21.62M-58.34%20.31M-52.26%26.71M-39.38%31.83M-33.02%40.34M
Deferred tax assets 19.39%82.22M40.98%87.6M38.86%85.89M7.83%80.98M9.60%68.86M-1.11%62.14M-1.54%61.85M9.42%75.11M42.90%62.83M42.90%62.83M
Usufruct assets -21.22%35.97M-26.88%35.07M-23.48%39.43M-23.64%42.79M42.37%45.65M30.66%47.97M31.63%51.53M27.71%56.03M65.96%32.07M67.30%36.71M
Other non current assets 31.82%1.61B21.71%1.33B-51.49%483.38M-39.47%521.23M84.06%1.22B60.03%1.1B57.96%996.51M17.51%861.19M15.89%663.23M47.32%684.41M
Total non current assets 16.09%5.67B20.48%5.47B8.11%4.67B13.51%4.63B30.57%4.89B27.04%4.54B25.86%4.32B25.46%4.08B25.15%3.74B25.64%3.57B
Total assets 12.64%8.58B11.93%8.46B10.27%8.33B8.48%7.99B8.65%7.62B12.76%7.56B14.91%7.55B12.46%7.36B14.18%7.01B21.73%6.71B
Liabilities
Current liabilities
Short term loan -2.04%352M28.58%462M44.80%332M16.98%279.09M50.30%359.32M56.86%359.32M54.58%229.29M60.85%238.58M139.07%239.07M129.07%229.07M
Notes payable and accounts payable 40.98%1.1B20.64%1.07B30.36%1.04B30.88%941.16M12.54%779.95M40.54%883.48M70.34%799.28M59.88%719.12M53.62%693.07M33.16%628.66M
-Notes payable 19.28%467.76M-15.25%381.97M-15.93%354.49M-4.02%330.31M2.11%392.16M61.19%450.72M115.71%421.66M60.84%344.15M68.06%384.06M6.27%279.62M
-Accounts payable 62.92%631.79M58.02%683.88M82.04%687.43M62.90%610.85M25.49%387.79M23.99%432.77M37.94%377.62M59.01%374.97M38.80%309.02M67.01%349.04M
Contract liabilities -24.45%35.78M-34.82%29.21M-53.87%44.34M-34.15%53.35M-0.40%47.36M2.15%44.82M62.64%96.12M70.15%81.01M-22.11%47.55M-7.28%43.88M
Advance receipts --0------0--0--0--------------0--0
Salaries payable 27.82%147.02M30.59%134.68M18.56%147.58M14.53%164.77M3.70%115.01M-0.97%103.13M-1.86%124.48M1.46%143.86M-10.06%110.91M-4.58%104.14M
Taxs payable 91.15%71.31M119.55%85.14M7.92%78.81M-16.61%87.92M-54.22%37.31M-44.67%38.78M-16.55%73.03M6.70%105.43M172.14%81.49M219.31%70.1M
Other payable (including interest and dividends) 28.19%642.24M22.49%620.34M12.05%586.06M5.76%532.35M2.01%500.99M-8.40%506.44M-3.13%523.05M-2.45%503.37M-7.09%491.14M-1.01%552.91M
-Other payable ----22.49%620.34M-------------8.40%506.44M-----2.45%503.37M-----1.01%552.91M
Non current liabilities due within one year 11.97%11.85M0.07%10.96M6.45%11.22M-19.51%11.86M12.03%10.58M-4.31%10.95M-14.56%10.54M-1.31%14.73M--9.45M--11.44M
Other current liabilities -49.63%2.99M-48.33%2.89M-27.29%4.7M-54.03%4.26M16.98%5.93M41.83%5.59M54.64%6.47M85.44%9.28M-20.61%5.07M-11.98%3.94M
Total current liabilities 27.27%2.36B23.49%2.41B20.64%2.25B14.29%2.07B10.65%1.86B18.76%1.95B28.65%1.86B27.64%1.82B29.01%1.68B25.17%1.64B
Current liabilities
Long term loan ----------0------0-----------------95.49%21.45K
Estimate liabilities -32.49%1.31M64.98%3.2M46.79%2.85M64.98%3.2M168.39%1.94M168.39%1.94M161.14%1.94M161.14%1.94M-8.17%723.3K-8.17%723.3K
Deferred tax liabilities 28.93%75.46M32.95%76.19M26.96%70.69M14.60%68.4M3.23%58.53M1.07%57.3M-1.82%55.68M-8.79%59.68M21.80%56.7M21.80%56.7M
Long term deferred income -6.69%259.57M-4.59%267.07M-1.13%264.82M-0.66%268.81M6.57%278.19M71.98%279.9M110.06%267.84M110.20%270.6M108.40%261.05M26.24%162.75M
Lease liabilities -37.90%24.06M-48.36%20.05M-27.64%30.78M-27.34%31.23M50.31%38.74M41.03%38.82M48.84%42.53M40.38%42.98M33.89%25.77M26.38%27.52M
Total non current liabilities -4.51%360.4M-3.03%366.5M0.31%369.13M-0.95%371.64M9.63%377.4M52.58%377.96M72.31%367.99M66.33%375.2M79.07%344.24M24.78%247.71M
Total liabilities 21.90%2.72B19.18%2.78B17.29%2.62B11.68%2.45B10.48%2.23B23.19%2.33B34.27%2.23B32.94%2.19B35.46%2.02B25.12%1.89B
Shareholders equity
Paid-in capital 0.00%861.03M0.00%861.03M0.00%861.03M0.00%861.03M0.00%861.03M-4.89%861.03M-4.89%861.03M-4.89%861.03M-4.89%861.03M8.07%905.32M
Capital reserve funds 0.18%1.72B0.18%1.72B0.18%1.72B0.18%1.72B0.72%1.72B-18.13%1.72B-18.13%1.72B-23.07%1.72B-22.11%1.71B19.03%2.1B
Surplus reserve funds 15.19%374.11M15.19%374.11M15.19%374.11M15.19%374.11M16.90%324.77M16.90%324.77M16.90%324.77M16.90%324.77M31.17%277.83M31.17%277.83M
Retained profit 16.93%2.86B17.38%2.68B13.92%2.71B13.96%2.54B15.68%2.44B18.22%2.29B16.91%2.38B19.07%2.23B20.52%2.11B21.34%1.93B
Less:Treasury stock ----------0------0--0----------00.00%437.62M
Other composite income -38.97%1.24M-26.70%1.42M-12.98%1.31M-24.33%1.04M178.93%2.04M353.72%1.94M430.53%1.51M1,749.25%1.37M483.11%731.34K272.25%427K
Specific reserves 29.15%12.82M29.04%12.82M29.11%12.82M29.04%12.82M24.55%9.93M24.66%9.94M24.59%9.93M24.66%9.94M26.93%7.97M26.93%7.97M
Shareholders equity without minority interests 8.73%5.83B8.69%5.66B7.29%5.68B7.12%5.51B7.93%5.36B8.67%5.2B8.31%5.3B5.85%5.15B7.27%4.97B20.41%4.79B
Minority interests 21.49%30.57M10.57%28.78M14.32%30.2M7.48%27.78M4.77%25.16M6.60%26.03M21.11%26.41M-31.47%25.85M26.75%24.02M30.09%24.42M
Total shareholder equity 8.79%5.86B8.70%5.69B7.33%5.71B7.12%5.54B7.91%5.39B8.66%5.23B8.37%5.32B5.57%5.17B7.34%4.99B20.45%4.81B
Total liabilityies and equity 12.64%8.58B11.93%8.46B10.27%8.33B8.48%7.99B8.65%7.62B12.76%7.56B14.91%7.55B12.46%7.36B14.18%7.01B21.73%6.71B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Participating Brokerage Firms
Participating Brokerage Firms
Intraday+1.56%
Biomedical
Biomedical
Intraday+1.54%
Medical Device Concept
Medical Device Concept
Intraday+1.47%